{
  "url": "https://openlegislation.uk/draft-misuse-of-drugs-act-1971-amendment-order-2018/article-2",
  "json_url": "https://openlegislation.uk/draft-misuse-of-drugs-act-1971-amendment-order-2018/article-2.json",
  "legislation": "ukdsi/2018/9780111173510",
  "legislation_title": "The Misuse of Drugs Act 1971 (Amendment) Order 2018",
  "legislation_url": "https://openlegislation.uk/draft-misuse-of-drugs-act-1971-amendment-order-2018",
  "path": "article/2",
  "kind": "article",
  "number": "2",
  "heading": "Amendments to the Misuse of Drugs Act 1971",
  "text": "(1) The following amendments are made to Schedule 2 to the Misuse of Drugs Act 1971.\n(2) In paragraph 1(b) of Part 3 (which specifies the drugs which are subject to control under that Act as Class C drugs)—\n(a) after “Furazabol.” insert—\n“Gabapentin (1-(aminomethyl)cyclohexaneacetic acid).”, and\n(b) after “Prasterone.” insert—\n“Pregabalin ((S)-3-(aminomethyl)-5-methylhexanoic acid).”.",
  "extent": null,
  "status": null,
  "version": "current",
  "annotations": [],
  "outstanding_effects": [],
  "provenance": {
    "source": "legislation.gov.uk",
    "source_url": "https://www.legislation.gov.uk/ukdsi/2018/9780111173510/article/2",
    "retrieved_at": "2026-10-30T15:03:48.239073+00:00"
  },
  "licence": "Open Government Licence v3.0",
  "licence_url": "https://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/",
  "attribution": "Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives."
}